featured
Fast-Acting Insulin Aspart Improves Glycemic Control in Basal-Bolus Treatment for Type 1 Diabetes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Diabetes Care
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Fast-Acting Insulin Aspart Improves Glycemic Control in Basal-Bolus Treatment for Type 1 Diabetes: Results of a 26-Week Multicenter, Active-Controlled, Treat-to-Target, Randomized, Parallel-Group Trial (Onset 1)
Diabetes Care 2017 Mar 29;[EPub Ahead of Print], D Russell-Jones, BW Bode, C De Block, E Franek, SR Heller, C Mathieu, A Philis-Tsimikas, L Rose, VC Woo, AB Østerskov, T Graungaard, RM BergenstalFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.